Annovis Stock Story

ANVS
 Stock
  

USD 11.34  0.14  1.22%   

Annovis investor sentiment overview provides quick insight into current market opportunities from investing in Annovis Bio. The current market sentiment together Annovis Bio's historical and current headlines can help investors to time the market. Many technical investors use Annovis Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please continue to Annovis Bio Hype Analysis, Annovis Bio Correlation and Annovis Bio Performance.
  
Refresh
Annovis Bio stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Annovis daily returns and investor perception about the current pice of Annovis Bio as well as its diversification or hedging effects on your existing portfolios.

Annovis Latest Sentiment Indicators

200 Day MA
18.32
Short Percent
0.0334
Short Ratio
4.23
Shares Short Prior Month
179.8 K
50 Day MA
10.51
52 Week Low
8.39
Shares Short
188 K

Annovis Bio Current Investor Sentiment

Investor biases related to Annovis Bio's public news can be used to forecast risks associated with investment in Annovis. The trend in average sentiment can be used to explain how an investor holding Annovis can time the market purely based on public headlines and social activities around Annovis Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Annovis Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Annovis Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Annovis Bio's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Annovis Bio.
Better Biotech Stock Biogen vs. Annovis Bio - Motley Fool
Better Biotech Stock Biogen vs. Annovis Bio Motley Fool

fool News
  
Better Biotech Stock Biogen vs. Annovis Bio Motley Fool

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Annovis Bio Fundamental Analysis

We analyze Annovis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annovis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annovis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Peers

Your Trending Equities

MNBEF  6.72   
0%
79.0%
JLKLX  1.79   
0%
21.0%
PRFT  0.89   
0%
10.0%
VGLT  0.83   
0%
9.0%
PANW  0.44   
0%
5.0%
TAXI  0.00   
0%
0%
HAR  0.00   
0%
0%
SSS  0.00   
0%
0%
HZNSF  0.00   
0%
0%
GDI  0.00   
0%
0%
PPCCF  0.00   
0%
0%
DPS  0.00   
0%
0%
LGV  0.10   
1.0%
0%
BCGPX  0.16   
1.0%
0%
VST  0.17   
2.0%
0%
AQNA  1.26   
14.0%
0%
INMB  1.45   
17.0%
0%
BNPQF  3.10   
36.0%
0%
SMNEY  3.34   
39.0%
0%
SONO  4.14   
49.0%
0%
ACRHF  8.43   
100.0%
0%
Please continue to Annovis Bio Hype Analysis, Annovis Bio Correlation and Annovis Bio Performance. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
100 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.